Zeena Williams

Zeena Williams is a senior associate director at Boehringer Ingelheim

Articles by Zeena Williams

Evaluating Progress in Analytical Quality by Design

ByElizabeth Hewitt,Andy Rignall,Mark D. Trone,Patrick Jackson,Marion Chatfield,Mark Argentine,Qinggang Wang,Shreekant Karmarkar,Andrea M. Pless,Zeena Williams,Kimber Barnett,David Semin,Yanqun Zhao,Ariane Marolewski

April 2nd 2017

The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.

Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach

ByFrank Diana,Jeff Hofer,Marion Chatfield,Nancy Benz,Yuan Huang,Mark Argentine,Qinggang Wang,Shreekant Karmarkar,Hafez Abdel-Kader,Lakshmy M. Nair,Hui Fang,Theresa Natishan,Andrea M. Pless,Rick Burdick,Zeena Williams

October 2nd 2014

A risk-based approach is recommended for analytical method comparability for HPLC assay and impurities methods.

Latest Updated Articles

Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Published: October 2nd 2014 | Updated:
Evaluating Progress in Analytical Quality by Design
Published: April 2nd 2017 | Updated:

Zeena Williams

Articles by Zeena Williams

Evaluating Progress in Analytical Quality by Design

Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach

Latest Updated Articles

Trending on Pharmaceutical Technology

Everything to Know About Pharmaceutical Tariffs in 2025

Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt

Challenges for the Global Manufacturing of Vaccines

Integrating Sustainability into the Core of Pharmaceutical Science

Outsourcing Partners Providing End-to-End Service